The association of body mass index and prostate-specific antigen in a population-based study-Reference-Cited by-同舟云学术

The association of body mass index and prostate-specific antigen in a population-based study

Published:2005 Issue:5 Volume:103 Page:1092-1095
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Baillargeon Jacques,Pollock Brad H.,Kristal Alan R.,Bradshaw Patrick,Hernandez Javier,Basler Joseph,Higgins Betsy,Lynch Steve,Rozanski Thomas,Troyer Dean,Thompson Ian

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference18 articles.

1. National Institutes of Health (NIH)/National Heart Lung, and Blood Institute (NHLBI). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity: the evidence report. Washington, DC: U.S. Government Press, 1998.

2. Annual Deaths Attributable to Obesity in the United States

3. Lifestyle and Anthropometric Risk Factors for Prostate Cancer in a Cohort of Iowa Men

4. Anthropometry in Relation to Prostate Cancer Risk in the Netherlands Cohort Study

5. Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is It a Necessity to Revise Normal Level of Prostate-Specific Antigen in Patients with Chronic Kidney Disease?;Nephro-Urology Monthly;2024-06-08

2. Body mass weighted PSA levels, new markers to predict locally advanced prostate cancer after prostatectomy;Journal of the Chinese Medical Association;2024-05-17

3. Can weight-adjusted waist circumference index become a single anthropometric predictor of prostate-specific antigen concentration? A National Health and Nutrition Examination Survey analysis (2003–2010);Journal of Investigative Medicine;2024-05-09

4. Serum Levels of Prostate Specific Antigen and Specific Reproductive Hormones Among Male Subjects with Benign Prostate Hyperplasia in Port Harcourt, Nigeria;Annals of Innovation in Medicine;2024-04-25

5. Drug‐target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk;Molecular Carcinogenesis;2024-03-22